Depression and Anxiety Trial, Recruiting NCT03417960 Sponsor: Medical University of South Carolina Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT03417960
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be able to understand and agree to take part in the study, and be able to complete questionnaires and assessments accurately.
  • You must be over 18 years old.
  • You must have been diagnosed with postpartum depression, meaning your symptoms started within the first year after giving birth.
  • You must score 14 or higher on a specific depression rating scale (called the HRSD17) at the start of the study (confirm with trial site).

Who may not be able to join:

  • You cannot currently be pregnant.
  • You cannot have a moderate or severe problem with substance use (such as alcohol or drugs), although tobacco use is an exception.
  • You cannot currently be experiencing symptoms of psychosis (such as hallucinations or delusions).
  • You cannot have a history of dementia or other significant memory or thinking problems.
  • You cannot have active thoughts of suicide that require hospital care, or have made a suicide attempt in the past 3 months.
  • You cannot have any medical reasons that would make receiving rTMS (a type of brain stimulation treatment) unsafe — for example, metal implants in the head or neck, a history of seizures, or any known brain injury (confirm with trial site).
  • You cannot have any unstable or poorly controlled medical conditions.
  • You cannot have experienced eclampsia (a serious condition involving seizures) during a previous pregnancy.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 843-792-8274

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 January 2018
Est. completion
30 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Determine feasibility and tolerability of accelerated iTBS for postpartum depression. The investigators hope to retain >80% of recruited patients (feasibility) and reach a full treatment dose of 120%rMT in >80% of enrolled women (tolerability).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov